People on the Move
CiToxLAB
French preclinical contract research organization (CRO) CiToxLAB has appointed former Galderma, Protéus and Transgène scientist Philippe Ancian as Senior Director of Biomarkers.
In the role he will help develop preclinical and clinical biomarkers at the company’s sites in Europe and North America.
Ancian’s work focuses on specialized genomics and proteomics platforms.
He joined CiT in 2005 to develop a functional genomics platform at the company’s site in Evreux, France before moving to Transgène as Senior Director of Vectorology and Biomarkers. CiT merged with LAB-Research Group in 2011.
The company’s platforms include functional genomics, flow cytometry immunophenotyping, mass spectrometry, protein and peptide analysis, immunohistochemistry and next generation sequencing.